Page 82 - Read Online

glioblastoma and metastatic brain cancers and refl ect disease cancer. Eur Urol 2015;67:33-41.
activity. Neuro Oncol 2012;14:689-700. 35. K orzeniewski N, Tosev G, Pahernik S, Hadaschik B,
23. von Bueren AO, Shalaby T, Rajtarova J, Stearns D, Hohenfellner M, Duensing S. Identifi cation of cell-free
Eberhart CG, Helson L, Arcaro A, Grotzer MA. microRNAs in the urine of patients with prostate cancer. Urol
Anti-proliferative activity of the quassinoid NBT-272 in Oncol 2015;33:16.e17-22.
childhood medulloblastoma cells. BMC Cancer 2007;7:19. 36. L e MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V,
24. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y, Lodish HF, Lim B. MicroRNA-125b is a novel negative
Ochiya T. Secretory mechanisms and intercellular transfer of regulator of p53. Genes Dev 2009;23:862-76.
microRNAs in living cells. J Biol Chem 2010;285:17442-52. 37. S and M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T,
25. Lukiw WJ, Alexandrov PN, Zhao Y, Hill JM, Bhattacharjee S. Altmeyer P, Bechara FG. Expression of microRNAs in basal cell
Spreading of Alzheimer’s disease infl ammatory signaling carcinoma. Br J Dermatol 2012;167:847-55.
through soluble micro-RNA. Neuroreport 2012;23:621-6. 38. S un X, Song Y, Tai X, Liu B, Ji W. MicroRNA expression and
26. Turchinovich A, Weiz L, Langheinz A, Burwinkel B. its detection in human supraglottic laryngeal squamous cell
Characterization of extracellular circulating microRNA. carcinoma. Biomed Rep 2013;1:743-746.
Nucleic Acids Res 2011;39:7223-33. 39. S un YM, Lin KY, Chen YQ. Diverse functions of miR-125
27. Snuderl M, Batista A, Kirkpatrick ND, Ruiz de Almodovar C, family in different cell contexts. J Hematol Oncol 2013;6:6.
Riedemann L, Walsh EC, Anolik R, Huang Y, Martin JD, 40. T ang F, Zhang R, He Y, Zou M, Guo L, Xi T. MicroRNA-125b
Kamoun W, Knevels E, Schmidt T, Farrar CT, Vakoc BJ, induces metastasis by targeting STARD13 in MCF-7 and
Mohan N, Chung E, Roberge S, Peterson T, Bais C, MDA-MB-231 breast cancer cells. PLoS One 2012;7:e35435.
Zhelyazkova BH, Yip S, Hasselblatt M, Rossig C, 41. W ang H, Tan G, Dong L, Cheng L, Li K, Wang Z, Luo H.
Niemeyer E, Ferrara N, Klagsbrun M, Duda DG, Fukumura D, Circulating MiR-125b as a marker predicting chemoresistance
Xu L, Carmeliet P, Jain RK. Targeting placental growth in breast cancer. PLoS One 2012;7:e34210.
factor/neuropilin 1 pathway inhibits growth and spread of 42. C heng HH, Mitchell PS, Kroh EM, Dowell AE, Chéry L,
medulloblastoma. Cell 2013;152:1065-76. Siddiqui J, Nelson PS, Vessella RL, Knudsen BS,
28. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Chinnaiyan AM, Pienta KJ, Morrissey C, Tewari M. Circulating
Sood AK, Calin GA. MicroRNAs in body fl uids - the mix of microRNA profi ling identifi es a subset of metastatic prostate
hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467-77. cancer patients with evidence of cancer-associated hypoxia.
29. Hannafon BN, Ding WQ. Intercellular Communication by PLoS One 2013;8:e69239.
Exosome-Derived microRNAs in Cancer. Int J Mol Sci 43. Ko saka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F,
2013;14:14240-69. Ochiya T. Neutral sphingomyelinase 2 (nSMase2)-dependent
30. Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated exosomal transfer of angiogenic microRNAs regulate cancer
circulating microRNAs as biomarkers of cancer. Molecules cell metastasis. J Biol Chem 2013;288:10849-59.
2014;19:1912-38. 44. Zh ang Y, Yang P, Wang XF. Microenvironmental regulation of
31. Mittelbrunn M, Sánchez-Madrid F. Intercellular cancer metastasis by miRNAs. Trends Cell Biol 2014;24:153-60.
communication: diverse structures for exchange of genetic 45. Salido-Guadarrama I, Romero-Cordoba S, Peralta-Zaragoza O,
information. Nat Rev Mol Cell Biol 2012;13:328-35. Hidalgo-Miranda A, Rodríguez-Dorantes M. MicroRNAs
32. F rampton AE, Krell J, Kazemier G, Giovannetti E. Serum transported by exosomes in body fl uids as mediators of intercellular
miR-1290 as a marker of pancreatic cancer - letter. Clin communication in cancer. Onco Targets Ther 2014;7:1327-38.
Cancer Res 2013;19:5250-1.
33. H ammond J, Johnson HM, Varas R, Ward CG. A qualitative
comparison of paper fl owsheets vs a computer-based clinical
information system. Chest 1991;99:155-7. How to cite this article: Shalaby T, Fiaschetti G, Baulande S,
34. H uang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, Gerber NU, Baumgartner M, Grotzer MA. Detection and quantifi cation
of extracellular microRNAs in medulloblastoma. J Cancer Metastasis
See W, Costello BA, Quevedo F, Tan W, Nandy D, Bevan GH, Treat 2015;1:67-75.
Longenbach S, Sun Z, Lu Y, Wang T, Thibodeau SN,
Boardman L, Kohli M, Wang L. Exosomal miR-1290 and Received: 30-01-2015; Accepted: 07-04-2015.
miR-375 as prognostic markers in castration-resistant prostate Source of Support: Nil, Confl ict of Interest: None declared.

Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 2 ¦ July 15, 2015 ¦ 75